ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,422,434, issued on Sept. 23.

"Systems and processes to screen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) of 2019 (COVID-19)" was invented by Melicia R. Gainey (Columbus, Ohio) and Dalia Natour (Columbus, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "Alternative antibodies to screen for SARS-CoV-2 are disclosed. One alternative antibody is Mouse Species Coronavirus (COVID-19, MERS, and SARS-CoV NP) Antibody, Catalog Number HM1056 ("E3-Antibody" or "E3"), from EastCoast Bio, Inc., PO Box 489, North Berwick, ME 03906, USA ("EastCoast Bio"). Another alternative antibody is a combination of the E3-Antibody and Mouse Species Coron...